Adult Grade III Meningioma
4 clinical trials · Condition
◉ Watch Adult Grade III Meningioma
| Record | Firm | Date |
|---|---|---|
| Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer (NCT00492089) | National Cancer Institute (NCI) | 2007-06-01 |
| Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors (NCT00110032) | National Cancer Institute (NCI) | 2005-06-01 |
| Imatinib Mesylate in Treating Patients With Recurrent Meningioma (NCT00045734) | National Cancer Institute (NCI) | 2003-02-01 |
| Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma (NCT00045110) | National Cancer Institute (NCI) | 2002-08-01 |
Track Adult Grade III Meningioma automatically
Every clearance here is in the API, with alerts when new ones post.